CELL LINES

Contributor Information
- Name Anne Lykkesfeldt
- Institute Danish Cancer Society
- Primary citation Kirkegaard et al. 2014. Cancer Lett. 344(1):90-100. PMID: 24513268.
Tool Details
- Tool name: T47D/S2 Cell Line
- Tool type: Cell Lines
- Tool sub-type: Continuous
- Parental cell line: T47D
- Organism: Human
- Tissue: Breast
- Gender: Female
- Cancer type: Breast cancer
- Disease: Cancer
- Model: Tumour line
- Conditional: Yes
- Application: Determining molecular mechanisms around tamoxifen resistance
-
Description: The T47D/S2 cell line is a control cell line for the tamoxifen resistant T47D/TR-1 and T47D/TR-2 cell lines. This cell line has been established by the reduction of the serum concentration in order to enable growth inhibiton with tamoxifen. T47D/S2 is adherent and the morphology is polygonal epithelial.
T47D/S2 cells express oestrogen receptor (alpha) and progesterone receptor.
This cell line allows the study of the mechanisms involved in tamoxifen resistant breast cancer cell growth. - Research area: Cancer; Drug development
- Production details: T47D/S2 cells have been established by reduction of the serum concentration to 2% fetal calf serum, in order to enable growth inhibition with tamoxifen.
- Cellosaurus ID: CVCL_1D45
- For Research Use Only
Target Details
- Target: Oestrogen receptor
Application Details
- Application: Determining molecular mechanisms around tamoxifen resistance
- Application notes: T47DS2 cells express ER alpha and progesterone receptor.
Handling
- Format: Frozen
- Passage number: Passage 151 (AL3707, AL3708)
- Growth medium: Phenol red free RPMI 1640 + 2% FCS + glutamax + 8ug Insulin/ml
- Temperature: 37° C
- Atmosphere: 5% CO2
- Storage conditions: Liquid Nitrogen
- Shipping conditions: Dry ice
- Mycoplasma free: Yes
- Biosafety level: 1
Related Tools
References
- • Larsen et al. 2015. PLoS One. 10(2):e0118346. PMID: 25706943.
- • Larsen et al. 2015. BMC Cancer. 15(1):1-15. PMID: 25885472.
- • Thrane et al. 2014. Oncogene. 34(32):4199-4210. PMID: 25362855.
- • Kirkegaard et al. 2014. Cancer Lett. 344(1):90-100. PMID: 24513268.